Ponatinib

3-Imidazo[1,2-b]pyridazin-3-ylethinyl-4-methyl-N-[4-(4-methylpiperazin-1-ylmethyl)-3-trifluormethylphenyl]benzamid

Stoffgruppe

Antineoplastisches Mittel (BCR-ABL-Tyrosinkinase-Inhibitor)